Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $29.1800 (4.81%) ($27.7500 - $29.3200) on Mon. Jul. 27, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.87% (three month average) | RSI | 48 | Latest Price | $29.1800(4.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -1.7% a day on average for past five trading days. | Weekly Trend | IOVA declines -1.6% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(48%) XBI(45%) ARKG(44%) IWO(42%) ARKK(40%) | Factors Impacting IOVA price | IOVA will decline at least -1.935% in a week (0% probabilities). VIXM(-22%) UUP(-16%) VXX(-12%) TBT(-6%) IYT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.935% (StdDev 3.87%) | Hourly BBV | 0 () | Intraday Trend | 4.8% | | | |
|
Resistance Level | $29.28 | 5 Day Moving Average | $28.79(1.35%) | 10 Day Moving Average | $29.48(-1.02%) | 20 Day Moving Average | $29.28(-0.34%) | To recent high | -28.8% | To recent low | 7.2% | Market Cap | $4.273b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |